Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
CHMP PROM minutes for the meeting on 19 January 2026
The 11th edition of the EFIM Day took place in Brussels on Friday, 16 October gathering representatives of EFIM National Societies, EFIM Executive Committee members, Working Group Chairs, Young Internists, and invited guests from across Europe for discussions on the future of Internal Medicine and the work of EFIM. A total of approximately 46 participants representing 26 national societies, EFIM Executive Committee, and invited speakers attended the meeting in Brussels.
EMEA-002644-PIP01-19-M01
EMEA-001841-PIP01-15
Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions
Vascular and cardiac prostheses – other - Notified Bodfy 0344 - 25/11/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
General medicine therapeutic treatment instruments - Notified Body 2797 - 12/05/2026 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)